Opportunity Overview
COMBINED SYNOPSIS / SOLICITATION
Title: Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
The solicitation number is 75N98026Q00906. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.
The associated NAICS code is 541380, and the small business size standard is N/A.
This requirement is NOT A SET-ASIDE for small businesses.
Description of Requirement:
Medicinal Chemistry
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.
The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.
The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors...
Title: Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
The solicitation number is 75N98026Q00906. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.
The associated NAICS code is 541380, and the small business size standard is N/A.
This requirement is NOT A SET-ASIDE for small businesses.
Description of Requirement:
Medicinal Chemistry
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.
The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.
The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | National Institutes of Health OLAO |
|---|---|
| Country | United States |
| Category | Government Procurement |
| NAICS | 541380 |
| PSC | 6505 |
| Published | July 31, 2026 |
| Procurement stage | Active solicitation |
| Closed | August 10, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 11, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Browse Similar Open Opportunities in United States
See every United States Government Procurement opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Government Procurement intelligence report in your inbox
A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.